Product
Tedizolid
4 clinical trials
5 indications
Indication
Gram-Positive InfectionsIndication
TuberculosisIndication
Multidrug-resistant tuberculosisIndication
Bone and Joint InfectionClinical trial
A Phase III Randomized, Active-comparator-Controlled Clinical Trial to Study the Safety and Efficacy of MK-1986 (Tedizolid Phosphate) and Comparator, in Subjects From Birth to Less Than 12 Years of Age With Acute Bacterial Skin and Skin Structure Infections (ABSSSI)Status: Completed, Estimated PCD: 2023-07-06
Clinical trial
A Phase 1, Single- and Multiple-Dose Safety and Pharmacokinetic Study of Oral and IV Tedizolid Phosphate (MK-1986) in Inpatients Under 2 Years OldStatus: Completed, Estimated PCD: 2023-03-18
Clinical trial
Evaluation of the Early Bactericidal Activity of Tedizolid and Linezolide Against Mycobacterium TuberculosisStatus: Recruiting, Estimated PCD: 2025-04-01
Clinical trial
Tolerability, Safety, and Efficacy of Tedizolid as Oral Treatment for Bone and Joint InfectionsStatus: Completed, Estimated PCD: 2021-03-23